Decoding the muscle transcriptome of patients with late onset Pompe disease reveals markers of disease progression
Alexandra Monceau,Rasya Gokul Nath,Xavier Suárez-Calvet,Olimpia Musumeci,Antonio Toscano,Biruta Kierdaszuk,Anna Kostera-Pruszczyk,Cristina Domínguez- González,Aurelio Hernández-Lain,Carmen Paradas,Eloy Rivas,George Papadimas,Constantinos Papadopoulos,Margarita Chrysanthou-Piterou,Eduard Gallardo,Montse Olivé,James Lilleker,Mark E Roberts,Domenica Marchese,Giulia Lunazzi,Holger Heyn,Esther Fernández-Simón,Elisa Villalobos,James Clark,Panos Katsikis,Catherine Collins,Priyanka Mehra,Zoe Laidler,Amy Vincent,Giorgio Tasca,Chiara Marini-Bettolo,Michela Guglieri,Volker Straub,Nina Raben,Jordi Díaz-Manera
DOI: https://doi.org/10.1093/brain/awae249
IF: 14.5
2024-07-26
Brain
Abstract:Late-onset Pompe Disease (LOPD) is a rare genetic disorder caused by the deficiency of acid alpha-glucosidase leading to progressive cellular dysfunction due to the accumulation of glycogen in the lysosome. The mechanism of relentless muscle damage – a classic manifestation of the disease – has been extensively studied by analysing the whole muscle tissue; however, little, if any, is known about transcriptional heterogeneity among nuclei within the multinucleated skeletal muscle cells. This is the first report of application of single nuclei RNA sequencing to uncover changes in the gene expression profile in muscle biopsies from eight patients with LOPD and four muscle samples from age and gender matched healthy controls. We matched these changes with histology findings using GeoMx Spatial Transcriptomics to compare the transcriptome of control myofibers from healthy individuals with non-vacuolated (histologically unaffected) and vacuolated (histologically affected) myofibers of LODP patients. We observed an increase in the proportion of slow and regenerative muscle fibers and macrophages in LOPD muscles. The expression of the genes involved in glycolysis was reduced, whereas the expression of the genes involved in the metabolism of lipids and amino acids was increased in non-vacuolated fibers, indicating early metabolic abnormalities. Additionally, we detected upregulation of autophagy genes, and downregulation of the genes involved in ribosomal and mitochondrial function leading to defective oxidative phosphorylation. The upregulation of the genes associated with inflammation, apoptosis and muscle regeneration was observed only in vacuolated fibers. Notably, enzyme replacement therapy – the only available therapy for the disease – showed a tendency to restore metabolism dysregulation, particularly within slow fibers. A combination of single nuclei RNA sequencing and spatial transcriptomics revealed the landscape of normal and the diseased muscle, and highlighted the early abnormalities associated with the disease progression. Thus, the application of these two new cutting-edge technologies provided insight into the molecular pathophysiology of muscle damage in LOPD and identified potential avenues for therapeutic intervention.
neurosciences,clinical neurology